Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
TXG
Showing 8 of 10 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in 10x Genomics, Inc.
Yes. Jacobs Levy Equity Management holds 2,019,883 shares of TXG (10x Genomics), worth $77.4M, as of its Q2 2026 13F filing. It reduced the position by 263,541 shares (-11.5%) from Q1 2026. Jacobs Levy Equity Management has held TXG since Q4 2024, across 7 quarterly 13F filings. TXG is 0.3% of Jacobs Levy Equity Management's reported 13F portfolio.
Current Value
$77.4M
Current Shares
2M
Total Value Change
+$77.4M
Total Shares Change
+2M
Quarter-by-Quarter History